Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996).
Greenberg PL, Sun Z, Miller KB, Bennett JM, Tallman MS, Dewald G, Paietta E, van der Jagt R, Houston J, Thomas ML, Cella D, Rowe JM. Greenberg PL, et al. Among authors: miller kb. Blood. 2009 Sep 17;114(12):2393-400. doi: 10.1182/blood-2009-03-211797. Epub 2009 Jun 29. Blood. 2009. PMID: 19564636 Free PMC article. Clinical Trial.
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995).
Cassileth PA, Lee SJ, Litzow MR, Miller KB, Stadtmauer EA, Tallman MS, Lazarus HM, Bennett JM, Paietta E, Dewald GW, Rowe JM; Eastern Cooperative Oncology Group. Cassileth PA, et al. Among authors: miller kb. Leuk Lymphoma. 2005 Jan;46(1):55-61. doi: 10.1080/10428190412331283288. Leuk Lymphoma. 2005. PMID: 15621781 Clinical Trial.
Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): an Eastern Cooperative Oncology Group Study.
Bennett JM, Young MS, Liesveld JL, Paietta E, Miller KB, Lazarus HM, Marsh RD, Friedenberg WR, Saba HT, Hayes FA, Dewald GW, Hiddemann W, Rowe JM. Bennett JM, et al. Among authors: miller kb. Am J Hematol. 2001 Jan;66(1):23-7. doi: 10.1002/1096-8652(200101)66:1<23::AID-AJH1002>3.0.CO;2-B. Am J Hematol. 2001. PMID: 11426487 Free article. Clinical Trial.
Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation.
Narayanasami U, Kanteti R, Morelli J, Klekar A, Al-Olama A, Keating C, O'Connor C, Berkman E, Erban JK, Sprague KA, Miller KB, Schenkein DP. Narayanasami U, et al. Among authors: miller kb. Blood. 2001 Oct 1;98(7):2059-64. doi: 10.1182/blood.v98.7.2059. Blood. 2001. PMID: 11567990 Free article. Clinical Trial.
Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor.
Schenkein DP, Koc Y, Alcindor T, Stadtmauer EA, Miller KB, Cooper BW, Partridge AH, Lazarus HM. Schenkein DP, et al. Among authors: miller kb. Biol Blood Marrow Transplant. 2000;6(4A):448-55. doi: 10.1016/s1083-8791(00)70037-1. Biol Blood Marrow Transplant. 2000. PMID: 10975514 Clinical Trial.
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
Foss FM, Wang XV, Luger SM, Jegede O, Miller KB, Stadtmauer EA, Whiteside TL, Avigan DE, Gascoyne RD, Arber D, Wagner H, Strair RK, Hogan WJ, Sprague KA, Lazarus HM, Litzow MR, Tallman MS, Horning SJ. Foss FM, et al. Among authors: miller kb. Transfusion. 2020 Aug;60(8):1867-1872. doi: 10.1111/trf.15798. Epub 2020 Jul 12. Transfusion. 2020. PMID: 32654201 Free PMC article. Clinical Trial.
Myelodysplastic syndromes.
Miller KB. Miller KB. Curr Treat Options Oncol. 2000 Apr;1(1):63-9. doi: 10.1007/s11864-000-0016-y. Curr Treat Options Oncol. 2000. PMID: 12057062 Review.
A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma.
Schenkein DP, Roitman D, Miller KB, Morelli J, Stadtmauer E, Pecora AL, Cassileth P, Fernandez H, Cooper BW, Kutteh L, Lazarus HM. Schenkein DP, et al. Among authors: miller kb. Biol Blood Marrow Transplant. 1997 Oct;3(4):210-6. Biol Blood Marrow Transplant. 1997. PMID: 9360783 Clinical Trial.
276 results